RMTI Financial Statements

Balance sheet, income statement, cash flow, and dividends for Rockwell Medical Inc (RMTI).


$65.93M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

RMTI Market Cap. (MRY)


RMTI Shares Outstanding (MRY)


RMTI Assets (MRY)


Total Assets

$59.21M

Total Liabilities

$26.62M

Total Investments

$5.94M

RMTI Income (MRY)


Revenue

$101.49M

Net Income

-$480.00K

Operating Expense

$16.88M

RMTI Cash Flow (MRY)


CF Operations

$4.20M

CF Investing

-$4.87M

CF Financing

$7.35M

RMTI Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

RMTI Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$59,208,000 (13.48%)

$52,173,000 (11.88%)

$46,635,000 (-3.99%)

$48,574,000 (-37.52%)

Assets Current

$37,030,000 (28.71%)

$28,770,000 (-18.52%)

$35,310,000 (0.06%)

$35,288,000 (-49.20%)

Assets Non-Current

$22,178,000 (-5.23%)

$23,403,000 (106.65%)

$11,325,000 (-14.76%)

$13,286,000 (60.48%)

Goodwill & Intangible Assets

$11,128,000 (-4.73%)

$11,680,000 (1168.19%)

$921,000 (0.00%)

$921,000 (0.00%)

Shareholders Equity

$32,586,000 (53.05%)

$21,291,000 (50.94%)

$14,106,000 (456.45%)

$2,535,000 (-92.58%)

Property Plant & Equipment Net

$10,344,000 (-6.12%)

$11,018,000 (28.04%)

$8,605,000 (-15.83%)

$10,223,000 (84.10%)

Cash & Equivalents

$15,662,000 (74.35%)

$8,983,000 (-11.08%)

$10,102,000 (-23.93%)

$13,280,000 (-72.72%)

Accumulated Other Comprehensive Income

$54,000 (5500.00%)

-$1,000 (-100.61%)

$163,000 (213.46%)

$52,000 (-8.77%)

Deferred Revenue

$475,000 (-8.83%)

$521,000 (-87.97%)

$4,331,000 (-46.90%)

$8,157,000 (-19.95%)

Total Investments

$5,940,000 (204.30%)

$1,952,000 (-82.86%)

$11,390,000 (24.37%)

$9,158,000 (-8.39%)

Investments Current

$5,940,000 (204.30%)

$1,952,000 (-82.86%)

$11,390,000 (24.37%)

$9,158,000 (-8.39%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$5,956,000 (-1.54%)

$6,049,000 (-14.68%)

$7,090,000 (26.63%)

$5,599,000 (10.02%)

Trade & Non-Trade Receivables

$0 (0%)

$10,901,000 (74.17%)

$6,259,000 (5.85%)

$5,913,000 (41.76%)

Trade & Non-Trade Payables

$2,869,000 (-36.47%)

$4,516,000 (11.42%)

$4,053,000 (8.40%)

$3,739,000 (-10.01%)

Accumulated Retained Earnings (Deficit)

-$397,678,000 (-0.12%)

-$397,198,000 (-2.17%)

-$388,759,000 (-5.05%)

-$370,080,000 (-9.68%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$12,604,000 (-6.21%)

$13,439,000 (-17.87%)

$16,363,000 (-43.37%)

$28,895,000 (20.71%)

Debt Current

$2,433,000 (11.45%)

$2,183,000 (-47.26%)

$4,139,000 (-57.86%)

$9,822,000 (741.65%)

Debt Non-Current

$10,171,000 (-9.64%)

$11,256,000 (-7.92%)

$12,224,000 (-35.91%)

$19,073,000 (-16.24%)

Total Liabilities

$26,622,000 (-13.79%)

$30,882,000 (-5.06%)

$32,529,000 (-29.34%)

$46,039,000 (5.65%)

Liabilities Current

$14,091,000 (-15.30%)

$16,637,000 (-5.96%)

$17,691,000 (-15.62%)

$20,966,000 (63.89%)

Liabilities Non-Current

$12,531,000 (-12.03%)

$14,245,000 (-4.00%)

$14,838,000 (-40.82%)

$25,073,000 (-18.55%)

RMTI Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$101,489,000 (21.38%)

$83,612,000 (14.84%)

$72,810,000 (17.57%)

$61,931,000 (-0.43%)

Cost of Revenue

$84,005,000 (12.14%)

$74,908,000 (8.98%)

$68,733,000 (6.81%)

$64,351,000 (8.20%)

Selling General & Administrative Expense

$16,857,000 (18.15%)

$14,267,000 (-19.57%)

$17,738,000 (-15.86%)

$21,081,000 (-12.36%)

Research & Development Expense

$19,000 (-98.28%)

$1,107,000 (-64.51%)

$3,119,000 (-54.37%)

$6,835,000 (-3.62%)

Operating Expenses

$16,876,000 (9.77%)

$15,374,000 (-26.29%)

$20,857,000 (-25.29%)

$27,916,000 (-10.37%)

Interest Expense

$1,254,000 (-45.50%)

$2,301,000 (18.85%)

$1,936,000 (-17.97%)

$2,360,000 (25.60%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$480,000 (94.31%)

-$8,439,000 (54.82%)

-$18,679,000 (42.83%)

-$32,674,000 (-5.78%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$480,000 (94.31%)

-$8,439,000 (54.82%)

-$18,679,000 (42.83%)

-$32,674,000 (-5.78%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$480,000 (94.31%)

-$8,439,000 (54.82%)

-$18,679,000 (42.83%)

-$32,674,000 (-5.78%)

Weighted Average Shares

$31,058,539 (33.17%)

$23,322,915 (136.38%)

$9,866,844 (15.72%)

$8,526,186 (24.02%)

Weighted Average Shares Diluted

$31,058,539 (33.17%)

$23,322,915 (136.38%)

$9,866,844 (15.72%)

$8,526,186 (24.02%)

Earning Before Interest & Taxes (EBIT)

$774,000 (112.61%)

-$6,138,000 (63.34%)

-$16,743,000 (44.77%)

-$30,314,000 (-4.49%)

Gross Profit

$17,484,000 (100.87%)

$8,704,000 (113.49%)

$4,077,000 (268.47%)

-$2,420,000 (-188.81%)

Operating Income

$608,000 (109.12%)

-$6,670,000 (60.25%)

-$16,780,000 (44.69%)

-$30,336,000 (-6.74%)

RMTI Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$4,866,000 (-59.80%)

-$3,045,000 (-27.09%)

-$2,396,000 (-870.42%)

$311,000 (-90.32%)

Net Cash Flow from Financing

$7,348,000 (-35.21%)

$11,342,000 (-31.81%)

$16,632,000 (863.29%)

-$2,179,000 (-103.44%)

Net Cash Flow from Operations

$4,202,000 (144.65%)

-$9,412,000 (45.95%)

-$17,414,000 (48.07%)

-$33,534,000 (-13.13%)

Net Cash Flow / Change in Cash & Cash Equivalents

$6,679,000 (696.87%)

-$1,119,000 (64.79%)

-$3,178,000 (91.02%)

-$35,402,000 (-195.97%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$12,361,000 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$3,855,000 (-140.16%)

$9,600,000 (553.90%)

-$2,115,000 (-353.90%)

$833,000 (-80.44%)

Capital Expenditure

-$1,011,000 (-255.99%)

-$284,000 (-1.07%)

-$281,000 (46.17%)

-$522,000 (50.10%)

Issuance (Repayment) of Debt Securities

-$1,204,000 (65.74%)

-$3,514,000 (73.36%)

-$13,193,000 (-478.64%)

-$2,280,000 (-111.18%)

Issuance (Purchase) of Equity Shares

$10,181,000 (-31.49%)

$14,861,000 (-50.17%)

$29,825,000 (29429.70%)

$101,000 (-99.76%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$5,000 (-25.00%)

-$4,000 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,292,000 (38.63%)

$932,000 (195.87%)

$315,000 (-66.60%)

$943,000 (98.53%)

Depreciation Amortization & Accretion

$4,140,000 (19.86%)

$3,454,000 (33.41%)

$2,589,000 (2.94%)

$2,515,000 (9.87%)

RMTI Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

17.20% (65.38%)

10.40% (85.71%)

5.60% (243.59%)

-3.90% (-188.64%)

Profit Margin

-0.50% (95.05%)

-10.10% (60.70%)

-25.70% (51.33%)

-52.80% (-6.24%)

EBITDA Margin

4.80% (250.00%)

-3.20% (83.51%)

-19.40% (56.79%)

-44.90% (-4.42%)

Return on Average Equity (ROAE)

-1.80% (96.54%)

-52.00% (68.27%)

-163.90% (27.25%)

-225.30% (-108.23%)

Return on Average Assets (ROAA)

-0.90% (95.11%)

-18.40% (51.45%)

-37.90% (30.33%)

-54.40% (-27.10%)

Return on Sales (ROS)

0.80% (110.96%)

-7.30% (68.26%)

-23.00% (52.97%)

-48.90% (-4.94%)

Return on Invested Capital (ROIC)

2.50% (111.26%)

-22.20% (52.56%)

-46.80% (39.85%)

-77.80% (-6.58%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-68 (-1231.25%)

-5.11 (-851.21%)

-0.54 (54.41%)

-1.18 (52.17%)

Price to Sales Ratio (P/S)

0.62 (18.41%)

0.53 (281.88%)

0.14 (-77.78%)

0.62 (-49.43%)

Price to Book Ratio (P/B)

2.02 (-20.01%)

2.53 (202.15%)

0.84 (-94.49%)

15.2 (449.46%)

Debt to Equity Ratio (D/E)

0.82 (-43.66%)

1.45 (-37.12%)

2.31 (-87.30%)

18.16 (1324.39%)

Earnings Per Share (EPS)

-0.03 (91.89%)

-0.37 (80.42%)

-1.89 (50.65%)

-3.83 (15.08%)

Sales Per Share (SPS)

3.27 (-8.84%)

3.58 (-51.42%)

7.38 (1.58%)

7.26 (-19.71%)

Free Cash Flow Per Share (FCFPS)

0.1 (124.76%)

-0.42 (76.80%)

-1.79 (55.11%)

-3.99 (10.53%)

Book Value Per Share (BVPS)

1.05 (14.90%)

0.91 (-36.15%)

1.43 (381.48%)

0.3 (-94.02%)

Tangible Assets Book Value Per Share (TABVPS)

1.55 (-10.83%)

1.74 (-62.53%)

4.63 (-17.11%)

5.59 (-49.99%)

Enterprise Value Over EBIT (EV/EBIT)

88 (980.00%)

-10 (-900.00%)

-1 (0.00%)

-1 (50.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

13.79 (160.72%)

-22.71 (-1424.43%)

-1.49 (7.40%)

-1.61 (29.46%)

Asset Turnover

1.84 (1.10%)

1.82 (23.64%)

1.48 (43.30%)

1.03 (19.35%)

Current Ratio

2.63 (52.00%)

1.73 (-13.38%)

2 (18.60%)

1.68 (-69.01%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$3,191,000 (132.91%)

-$9,696,000 (45.20%)

-$17,695,000 (48.04%)

-$34,056,000 (-10.98%)

Enterprise Value (EV)

$67,768,364 (11.16%)

$60,963,463 (189.07%)

$21,089,163 (-52.85%)

$44,731,216 (-26.60%)

Earnings Before Tax (EBT)

-$480,000 (94.31%)

-$8,439,000 (54.82%)

-$18,679,000 (42.83%)

-$32,674,000 (-5.78%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$4,914,000 (283.08%)

-$2,684,000 (81.04%)

-$14,154,000 (49.08%)

-$27,799,000 (-4.03%)

Invested Capital

$30,931,000 (9.25%)

$28,312,000 (-17.42%)

$34,284,000 (-18.95%)

$42,302,000 (7.67%)

Working Capital

$22,939,000 (89.06%)

$12,133,000 (-31.14%)

$17,619,000 (23.02%)

$14,322,000 (-74.73%)

Tangible Asset Value

$48,080,000 (18.74%)

$40,493,000 (-11.42%)

$45,714,000 (-4.07%)

$47,653,000 (-37.97%)

Market Capitalization

$65,930,364 (22.44%)

$53,845,463 (356.04%)

$11,807,163 (-69.35%)

$38,526,216 (-59.24%)

Average Equity

$26,465,500 (63.17%)

$16,219,750 (42.34%)

$11,395,000 (-21.43%)

$14,502,500 (-49.22%)

Average Assets

$55,010,750 (20.05%)

$45,822,000 (-7.14%)

$49,343,250 (-17.90%)

$60,101,500 (-16.64%)

Invested Capital Average

$31,357,250 (13.42%)

$27,646,750 (-22.70%)

$35,765,750 (-8.17%)

$38,947,500 (-2.05%)

Shares

32,318,806 (13.44%)

28,489,663 (144.91%)

11,632,673 (36.18%)

8,542,398 (0.42%)